Crestchem Limited posted a net profit of ₹2.71 crore for FY26. The company also recommended a final dividend of ₹1.50 per share and announced the formation of a new subsidiary, Oleo Biosciences.
Crestchem Ltd FY26 Results and Expansion
Crestchem Ltd reported revenue of ₹29.61 crore and a net profit of ₹2.71 crore for the financial year ended March 31, 2026. **Reader Takeaway:** Stable FY26 profits and dividend announced; new subsidiary Oleo Biosciences is pre-operational, requiring monitoring. ## What just happened Crestchem Limited has announced its financial results for the fiscal year 2025-26. The company posted revenue from operations at ₹29.61 crore and a net profit of ₹2.71 crore. The Earnings Per Share (EPS) for the period stood at ₹9.03. Additionally, the Board of Directors recommended a final dividend of ₹1.50 per equity share (15% on a face value of ₹10) for FY26, subject to shareholder approval. ## Why this matters The results indicate a stable financial performance for the year. The dividend payout provides a direct return to shareholders. The formation of a new subsidiary signals a strategic move towards future growth, although its operational status needs to be tracked. ## The backstory Crestchem Limited operates in the chemicals sector. The company's recent filings indicate a consistent approach to financial reporting and dividend distribution. ## What changes now Investors will be looking forward to the Annual General Meeting for the final dividend approval. The key focus will be on the progress of the new subsidiary, Oleo Biosciences Private Limited, which was incorporated recently and is based in Bangalore. Crestchem plans to invest up to ₹2.25 crore in this subsidiary. ## Risks to watch While the subsidiary Oleo Biosciences has been established, it has not yet commenced commercial operations as of March 31, 2026. Investors should monitor the timeline for its operational launch and the effective deployment of the approved investment. ## Management and Leadership The company also approved the reappointment and remuneration of key management personnel, including Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel, for extended five-year terms, ensuring leadership continuity. ## Context metrics (time-bound) * **Revenue (FY26):** ₹29.61 crore * **Net Profit (FY26):** ₹2.71 crore * **Basic/Diluted EPS (FY26):** ₹9.03 * **Final Dividend:** ₹1.50 per share (15%) * **Subsidiary Investment Approved:** Up to ₹2.25 crore
Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.
